1261276-96-3

Upstream product

• 153894-33-8 2-carboxy-4,5,6-trihydrothiopheno<3,2-d><1>benzazepine 
• 153894-28-1 2-carbethoxy-4,5,6-trihydro-6-tosylthiopheno<3,2-d><1>benzazepin 
• 153894-24-7 5-chloro-1-tosyl-2,3-dihydro-1H-benzo[b]azepine-4-carbaldehyde 
• 100627-39-2 N-(3-ethoxycarbonyl-propyl)-N-(toluene-4-sulfonyl)-anthranilic acid methyl ester 
• 134-20-3 2-carbomethoxyaniline 
• 1261276-94-1 N-cyclopropyl-5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxamide 
• 122-04-3 4-nitro-benzoyl chloride 
• 50998-74-8 methyl N-tosylanthranilate 
• 24310-36-9 1-tosyl-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one 

Downstream Products

• 1516772-44-3 AZ-27 
• 1261275-80-2 C₃₃H₃₁N₃O₃S 
• 1261275-78-8 C₃₂H₂₉N₅O₃S 
• 1261275-76-6 C₃₄H₂₇N₃O₃S₂ 
• 1261275-72-2 C₃₃H₂₉F₂N₅O₃S 
• 1261275-70-0 C₃₆H₂₈FN₃O₃S 
• 1261275-68-6 C₃₂H₂₇F₂N₅O₃S 
• 1261275-65-3 C₂₉H₂₃BrN₄O₃S 
• 1261275-61-9 C₃₄H₃₂N₄O₃S 
• 1261275-59-5 C₃₀H₂₄IN₃O₃S 
• 1261275-57-3 C₂₉H₂₃BrN₄O₃S 
• 1261277-27-3 C₂₉H₂₃BrN₄O₃S 
• 1261277-25-1 C₂₉H₂₄ClN₅O₃S 
• 1261275-63-1 C₂₉H₂₃BrN₄O₃S 

Relevant academic research and scientific papers

Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor

Targeting viral polymerases has been a proven and attractive strategy for antiviral drug discovery. Herein we describe our effort in improving the antiviral activity and physical properties of a series of benzothienoazepine compounds as respiratory syncyt

ANTI-RSV COMPOUNDS

The present invention relates to anti-RSV compounds of Formula (I) and methods for use of the compounds in the treatment and prevention of RSV infection.